NVS Novartis AG
Healthcare$152.01+0.16%ClosedMarket Cap: $290.05B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$141.00
Target (Median)
$141.00
Target Range
$112.00 - $170.00
Upside from current price: -7.2%
Rating Distribution
3 Strong Buy2 Buy5 Hold2 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-26 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-01-06 | Barclays | upgrade | Equal Weight | Underweight |
| 2025-12-08 | JP Morgan | upgrade | Overweight | Neutral |
| 2025-09-12 | Goldman Sachs | downgrade | Sell | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.65 | $60.23B | 7 |
| Sun Dec 31 | $10.76 | $64.10B | 5 |
| Mon Dec 31 | $11.64 | $66.81B | 2 |
| Tue Dec 31 | $12.59 | $69.81B | 5 |